دورية أكاديمية

Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer

التفاصيل البيبلوغرافية
العنوان: Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer
المؤلفون: Mandarano, Martina, Orecchini, Elena, Bellezza, Guido, Vannucci, Jacopo, Ludovini, Vienna, Baglivo, Sara, Tofanetti, Francesca Romana, Chiari, Rita, Loreti, Elisabetta, Puma, Francesco, Sidoni, Angelo, Belladonna, Maria Laura
المساهمون: Mandarano, Martina, Orecchini, Elena, Bellezza, Guido, Vannucci, Jacopo, Ludovini, Vienna, Baglivo, Sara, Tofanetti, Francesca Romana, Chiari, Rita, Loreti, Elisabetta, Puma, Francesco, Sidoni, Angelo, Belladonna, Maria Laura
بيانات النشر: MDPI
ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
سنة النشر: 2021
المجموعة: Sapienza Università di Roma: CINECA IRIS
مصطلحات موضوعية: immunohistochemical biomarker, indoleamine-2,3-dioxygenase 1 (IDO1), kynurenine/tryptophan (Kyn/Trp) ratio, non-small cell lung cancer (NSCLC), serum biomarker, adenocarcinoma of lung, adult, aged, 80 and over, B7-H1 antigen, biomarkers, tumor, carcinoma, non-small-cell lung, squamous cell, female, follow-up studie, human, indoleamine-pyrrole 2,3,-dioxygenase, kynurenine, lung neoplasm, lymphocytes, tumor-infiltrating, male, middle aged, neoplasm recurrence, local, prognosi, survival rate, tryptophan
الوصف: The enzyme indoleamine 2,3-dioxygenase 1 (IDO1) degrade tryptophan (Trp) into kynurenine (Kyn) at the initial step of an enzymatic pathway affecting T cell proliferation. IDO1 is highly expressed in various cancer types and associated with poor prognosis. Nevertheless, the serum Kyn/Trp concentration ratio has been suggested as a marker of cancer-associated immune suppression. We measured Kyn and Trp in blood samples of a wide cohort of non-small-cell lung cancer (NSCLC) patients, before they underwent surgery, and analyzed possible correlations of the Kyn/Trp ratio with either IDO1 expression or clinical-pathological parameters. Low Kyn/Trp significantly correlated with low IDO1 expression and never-smoker patients; while high Kyn/Trp was significantly associated with older (>= 68 years) patients, advanced tumor stage, and squamous cell carcinoma (Sqcc), rather than the adenocarcinoma (Adc) histotype. Moreover, high Kyn/Trp was associated, among the Adc group, with higher tumor stages (II and III), and, among the Sqcc group, with a high density of tumor-infiltrating lymphocytes. A trend correlating the high Kyn/Trp ratio with the probability of recurrences from NSCLC was also found. In conclusion, high serum Kyn/Trp ratio, associated with clinical and histopathological parameters, may serve as a serum biomarker to optimize risk stratification and therapy of NSCLC patients.
نوع الوثيقة: article in journal/newspaper
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33922388; info:eu-repo/semantics/altIdentifier/wos/WOS:000650354800001; volume:22; issue:9; numberofpages:14; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11573/1660546Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104497944
DOI: 10.3390/ijms22094403
الإتاحة: https://doi.org/10.3390/ijms22094403Test
https://hdl.handle.net/11573/1660546Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.10517747
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.10517747
927
3
Academic Journal
academicJournal
926.820373535156
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.10517747&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.3390/ijms22094403# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Mandarano%2C+Martina%22">Mandarano, Martina</searchLink><br /><searchLink fieldCode="AR" term="%22Orecchini%2C+Elena%22">Orecchini, Elena</searchLink><br /><searchLink fieldCode="AR" term="%22Bellezza%2C+Guido%22">Bellezza, Guido</searchLink><br /><searchLink fieldCode="AR" term="%22Vannucci%2C+Jacopo%22">Vannucci, Jacopo</searchLink><br /><searchLink fieldCode="AR" term="%22Ludovini%2C+Vienna%22">Ludovini, Vienna</searchLink><br /><searchLink fieldCode="AR" term="%22Baglivo%2C+Sara%22">Baglivo, Sara</searchLink><br /><searchLink fieldCode="AR" term="%22Tofanetti%2C+Francesca+Romana%22">Tofanetti, Francesca Romana</searchLink><br /><searchLink fieldCode="AR" term="%22Chiari%2C+Rita%22">Chiari, Rita</searchLink><br /><searchLink fieldCode="AR" term="%22Loreti%2C+Elisabetta%22">Loreti, Elisabetta</searchLink><br /><searchLink fieldCode="AR" term="%22Puma%2C+Francesco%22">Puma, Francesco</searchLink><br /><searchLink fieldCode="AR" term="%22Sidoni%2C+Angelo%22">Sidoni, Angelo</searchLink><br /><searchLink fieldCode="AR" term="%22Belladonna%2C+Maria+Laura%22">Belladonna, Maria Laura</searchLink> )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Mandarano, Martina<br />Orecchini, Elena<br />Bellezza, Guido<br />Vannucci, Jacopo<br />Ludovini, Vienna<br />Baglivo, Sara<br />Tofanetti, Francesca Romana<br />Chiari, Rita<br />Loreti, Elisabetta<br />Puma, Francesco<br />Sidoni, Angelo<br />Belladonna, Maria Laura )
Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => MDPI<br />ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => Sapienza Università di Roma: CINECA IRIS )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22immunohistochemical+biomarker%22">immunohistochemical biomarker</searchLink><br /><searchLink fieldCode="DE" term="%22indoleamine-2%2C3-dioxygenase+1+%28IDO1%29%22">indoleamine-2,3-dioxygenase 1 (IDO1)</searchLink><br /><searchLink fieldCode="DE" term="%22kynurenine%2Ftryptophan+%28Kyn%2FTrp%29+ratio%22">kynurenine/tryptophan (Kyn/Trp) ratio</searchLink><br /><searchLink fieldCode="DE" term="%22non-small+cell+lung+cancer+%28NSCLC%29%22">non-small cell lung cancer (NSCLC)</searchLink><br /><searchLink fieldCode="DE" term="%22serum+biomarker%22">serum biomarker</searchLink><br /><searchLink fieldCode="DE" term="%22adenocarcinoma+of+lung%22">adenocarcinoma of lung</searchLink><br /><searchLink fieldCode="DE" term="%22adult%22">adult</searchLink><br /><searchLink fieldCode="DE" term="%22aged%22">aged</searchLink><br /><searchLink fieldCode="DE" term="%2280+and+over%22">80 and over</searchLink><br /><searchLink fieldCode="DE" term="%22B7-H1+antigen%22">B7-H1 antigen</searchLink><br /><searchLink fieldCode="DE" term="%22biomarkers%22">biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22tumor%22">tumor</searchLink><br /><searchLink fieldCode="DE" term="%22carcinoma%22">carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22non-small-cell+lung%22">non-small-cell lung</searchLink><br /><searchLink fieldCode="DE" term="%22squamous+cell%22">squamous cell</searchLink><br /><searchLink fieldCode="DE" term="%22female%22">female</searchLink><br /><searchLink fieldCode="DE" term="%22follow-up+studie%22">follow-up studie</searchLink><br /><searchLink fieldCode="DE" term="%22human%22">human</searchLink><br /><searchLink fieldCode="DE" term="%22indoleamine-pyrrole+2%2C3%2C-dioxygenase%22">indoleamine-pyrrole 2,3,-dioxygenase</searchLink><br /><searchLink fieldCode="DE" term="%22kynurenine%22">kynurenine</searchLink><br /><searchLink fieldCode="DE" term="%22lung+neoplasm%22">lung neoplasm</searchLink><br /><searchLink fieldCode="DE" term="%22lymphocytes%22">lymphocytes</searchLink><br /><searchLink fieldCode="DE" term="%22tumor-infiltrating%22">tumor-infiltrating</searchLink><br /><searchLink fieldCode="DE" term="%22male%22">male</searchLink><br /><searchLink fieldCode="DE" term="%22middle+aged%22">middle aged</searchLink><br /><searchLink fieldCode="DE" term="%22neoplasm+recurrence%22">neoplasm recurrence</searchLink><br /><searchLink fieldCode="DE" term="%22local%22">local</searchLink><br /><searchLink fieldCode="DE" term="%22prognosi%22">prognosi</searchLink><br /><searchLink fieldCode="DE" term="%22survival+rate%22">survival rate</searchLink><br /><searchLink fieldCode="DE" term="%22tryptophan%22">tryptophan</searchLink> )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The enzyme indoleamine 2,3-dioxygenase 1 (IDO1) degrade tryptophan (Trp) into kynurenine (Kyn) at the initial step of an enzymatic pathway affecting T cell proliferation. IDO1 is highly expressed in various cancer types and associated with poor prognosis. Nevertheless, the serum Kyn/Trp concentration ratio has been suggested as a marker of cancer-associated immune suppression. We measured Kyn and Trp in blood samples of a wide cohort of non-small-cell lung cancer (NSCLC) patients, before they underwent surgery, and analyzed possible correlations of the Kyn/Trp ratio with either IDO1 expression or clinical-pathological parameters. Low Kyn/Trp significantly correlated with low IDO1 expression and never-smoker patients; while high Kyn/Trp was significantly associated with older (>= 68 years) patients, advanced tumor stage, and squamous cell carcinoma (Sqcc), rather than the adenocarcinoma (Adc) histotype. Moreover, high Kyn/Trp was associated, among the Adc group, with higher tumor stages (II and III), and, among the Sqcc group, with a high density of tumor-infiltrating lymphocytes. A trend correlating the high Kyn/Trp ratio with the probability of recurrences from NSCLC was also found. In conclusion, high serum Kyn/Trp ratio, associated with clinical and histopathological parameters, may serve as a serum biomarker to optimize risk stratification and therapy of NSCLC patients. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/33922388; info:eu-repo/semantics/altIdentifier/wos/WOS:000650354800001; volume:22; issue:9; numberofpages:14; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; https://hdl.handle.net/11573/1660546; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85104497944 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.3390/ijms22094403 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.3390/ijms22094403<br />https://hdl.handle.net/11573/1660546 )
Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => info:eu-repo/semantics/openAccess )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.10517747 )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.3390/ijms22094403 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => immunohistochemical biomarker [Type] => general ) [1] => Array ( [SubjectFull] => indoleamine-2,3-dioxygenase 1 (IDO1) [Type] => general ) [2] => Array ( [SubjectFull] => kynurenine/tryptophan (Kyn/Trp) ratio [Type] => general ) [3] => Array ( [SubjectFull] => non-small cell lung cancer (NSCLC) [Type] => general ) [4] => Array ( [SubjectFull] => serum biomarker [Type] => general ) [5] => Array ( [SubjectFull] => adenocarcinoma of lung [Type] => general ) [6] => Array ( [SubjectFull] => adult [Type] => general ) [7] => Array ( [SubjectFull] => aged [Type] => general ) [8] => Array ( [SubjectFull] => 80 and over [Type] => general ) [9] => Array ( [SubjectFull] => B7-H1 antigen [Type] => general ) [10] => Array ( [SubjectFull] => biomarkers [Type] => general ) [11] => Array ( [SubjectFull] => tumor [Type] => general ) [12] => Array ( [SubjectFull] => carcinoma [Type] => general ) [13] => Array ( [SubjectFull] => non-small-cell lung [Type] => general ) [14] => Array ( [SubjectFull] => squamous cell [Type] => general ) [15] => Array ( [SubjectFull] => female [Type] => general ) [16] => Array ( [SubjectFull] => follow-up studie [Type] => general ) [17] => Array ( [SubjectFull] => human [Type] => general ) [18] => Array ( [SubjectFull] => indoleamine-pyrrole 2,3,-dioxygenase [Type] => general ) [19] => Array ( [SubjectFull] => kynurenine [Type] => general ) [20] => Array ( [SubjectFull] => lung neoplasm [Type] => general ) [21] => Array ( [SubjectFull] => lymphocytes [Type] => general ) [22] => Array ( [SubjectFull] => tumor-infiltrating [Type] => general ) [23] => Array ( [SubjectFull] => male [Type] => general ) [24] => Array ( [SubjectFull] => middle aged [Type] => general ) [25] => Array ( [SubjectFull] => neoplasm recurrence [Type] => general ) [26] => Array ( [SubjectFull] => local [Type] => general ) [27] => Array ( [SubjectFull] => prognosi [Type] => general ) [28] => Array ( [SubjectFull] => survival rate [Type] => general ) [29] => Array ( [SubjectFull] => tryptophan [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mandarano, Martina ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Orecchini, Elena ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bellezza, Guido ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vannucci, Jacopo ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ludovini, Vienna ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Baglivo, Sara ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tofanetti, Francesca Romana ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chiari, Rita ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Loreti, Elisabetta ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Puma, Francesco ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Sidoni, Angelo ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Belladonna, Maria Laura ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mandarano, Martina ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Orecchini, Elena ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Bellezza, Guido ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Vannucci, Jacopo ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ludovini, Vienna ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Baglivo, Sara ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tofanetti, Francesca Romana ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Chiari, Rita ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Loreti, Elisabetta ) ) ) [21] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Puma, Francesco ) ) ) [22] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Sidoni, Angelo ) ) ) [23] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Belladonna, Maria Laura ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2021 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) [1] => Array ( [Type] => issn-locals [Value] => edsbas.oa ) ) ) ) ) ) )
IllustrationInfo